The present invention relates to compounds useful as promoters of the SMN2 gene. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of Spinal Muscular Atrophy.
本发明涉及一种作为SMN2
基因促进剂有用的化合物。本发明还提供了包含该化合物的药学上可接受的组合物,并提供了使用该组合物治疗脊髓肌肉萎缩症的方法。